PREDICTORS OF CONTINUOUS HOSPITAL STAY IN ADULT PATIENTS WITH ACQUIRED VALVULAR DISEASE, OPERATED WITH HYPOTHERMIC AND NORMOTHERMIC CARDIOPULMONARY BYPASS

PREDICTORS OF CONTINUOUS HOSPITAL STAY IN ADULT PATIENTS WITH ACQUIRED VALVULAR DISEASE, OPERATED WITH HYPOTHERMIC AND NORMOTHERMIC CARDIOPULMONARY BYPASS

Goal of the study: to identify the predictors of continuous hospital stay in adult patients with acquired valvular disease, operated with hypothermic and normothermic cardiopulmonary bypass due definitive repair of the disease. Materials and methods: 140 patients who had surgical treatment of acquir...

Full description

Bibliographic Details
Main Authors:	D. G. Shakhin, V. A. Shmyrev, S. M. Efremov, D. N. Ponomarev, G. B. Moroz, I. A. Kornilov, A. N. Shilova, V. N. Lomivorotov, O. V. Kuleshov, M. A. Novikov, V. V. Lomivorotov
Format:	Article
Language:	Russian
Published:	New Terra Publishing House 2017-12-01
Series:	Вестник анестезиологии и реаниматологии
Subjects:	cardiopulmonary bypass hypothermia acquired valvular disease nt-probnp
Online Access:	https://www.vair-journal.com/jour/article/view/73

Similar Items

Normothermal or Hypothermal Extracorporeal Circulation Regimens in Patients with Acquired Heart Disease
by: V. V. Lomivorotov, et al.
Published: (2013-08-01)

POST-SURGERY CHANGES IN THE RATES OF ACID-BASE BALANCE AND BLOOD GAS CONTENT IN SURGICAL TREATMENT OF ACQUIRED CARDIAC DEFECTS UNDER CONDITIONS OF NORMAL AND HYPOTHERMIC CARDIOPULMONARY BYPASS
by: V. V. Lomivorotov, et al.
Published: (2017-11-01)

NT-proBNP AN IMPORTANT MARKER IN THE DIAGNOSTIC ALGORITHM IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AND HEART FAILURE
by: Olga Bernaz, et al.
Published: (2024-05-01)

NT-proBNP AN IMPORTANT MARKER IN THE DIAGNOSTIC ALGORITHM IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AND HEART FAILURE
by: Olga Bernaz, et al.
Published: (2024-05-01)

N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs
by: I G Kirillova, et al.
Published: (2016-05-01)

The clinical value of determination of natriuretic peptides in acute coronary syndrome
by: Ekaterina Viktorovna Shreyder, et al.
Published: (2010-09-01)

Relationships between the activity of neurohormonal systems and intracardiac hemodynamics in patients with heart failure: focus on galectin-3
by: V. I. Podzolkov, et al.
Published: (2022-05-01)

Prognostic value of pathogenetic therapy-induced changes in NT-proBNP in patients with chronic heart failure
by: E M Mezhonov, et al.
Published: (2012-09-01)

N-terminal fragment of the brain natriuretic peptide and proinflammatory cytokines in patients with coronary heart diseas
by: S V Shalaev, et al.
Published: (2009-05-01)

Assessment of N-terminal pro-brain natriuretic peptide in patients with arrhythmia due to undifferentiated connective tissue disease
by: E. N. Loginova, et al.
Published: (2023-11-01)

Part II. Comparison of Neurodevelopmental Outcomes Between Normothermic and Hypothermic Pediatric Cardiopulmonary Bypass
by: Claire E. Hannon, et al.
Published: (2019-11-01)

Comparison of Early Outcomes for Normothermic and Hypothermic Cardiopulmonary Bypass in Children Undergoing Congenital Heart Surgery
by: Antonio F. Corno, et al.
Published: (2018-08-01)

Level and correlations of soluble suppression of tumorigenicity 2 protein in heart failure and its relationship with clinical and paraclinical characteristics of patients
by: A. Ya. Kravchenko, et al.
Published: (2022-06-01)

IMPACT OF ANTIRHEUMATIC THERAPY ON THE LEVEL OF N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
by: I. G. Kirillova, et al.
Published: (2018-07-01)

POSITIVE IMPACT OF INFUSION WITH LEVOSIMENDAN ON THE ELDER PATIENTS (60-75 YEARS OLD) WITH LOWER EJECTION FRACTION OF THE LEFT VENTRICLE (< 50%) IN THE PERI-OPERATIVE PERIOD IN NON-CARDIAC SURGERY
by: Yu. V. Ubasev, et al.
Published: (2018-01-01)

BIOMARKERS OF MYOCARDIAL STRESS AND FIBROSIS FOR CLINICAL OUTCOMES ASSESSMENT IN POST MYOCARDIAL INFARCTION HEART FAILURE PATIENTS
by: N V Shilyaeva, et al.
Published: (2018-03-01)

Investigating the diagnostic accuracy of vertebral heart score, vertebral left atrium score and thoracic width measurement in cats with suspected cardiac problems
by: B. Ozdil, et al.
Published: (2025-03-01)

Serum Levels of NT-Pro BNP in Patients with Preeclampsia
by: Nguyen TX, et al.
Published: (2022-04-01)

Incidence of Atrial Fibrillation in Persons with Very High Serum Levels of N-Terminal Pro-B-Type Natriuretic Peptide: The Multi-Ethnic Study of Atherosclerosis
by: Weiss NS, et al.
Published: (2021-04-01)

Serum NT-proBNP levels as a marker for cardiopulmonary function in preeclampsia
by: H.M. Kim, et al.
Published: (2020-08-01)

SST2 and NT-proBNP biomarkers in prediction of COVID-19
by: O.O. Samchuk, et al.
Published: (2023-06-01)

Chronic Heart Failure in Early Rheumatoid Arthritis Patients Prior to Basic Antirheumatic Therapy
by: I. G. Kirillova, et al.
Published: (2020-03-01)

The course of chronic heart failure in patients with early rheumatoid arthritis on the anti-rheumatic therapy
by: I. G. Kirillova, et al.
Published: (2019-11-01)

Kalp Hastalığı Olmayan Romatoid Artritli Hastalarda Hastalık Aktivitesi İle NT-pro BNP Düzeyleri Arasındaki İlişki
by: Bülent Bütün, et al.
Published: (2019-01-01)

Serum Ürik Asit Düzeyinin Kardiyak Disfonksiyonda Prognostik bir Önemi Var mıdır?
by: Canan Topçuoğlu, et al.
Published: (2018-09-01)

Associations of NT-proBNP and hepcidin levels with clinical and laboratory parameters in patients with heart failure with various severity of left ventricular systolic dysfunction
by: V. I. Podzolkov, et al.
Published: (2020-09-01)

Time course of changes in the level of N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with rheumatoid arthritis during therapy with an interleukin-6 receptor inhibitor
by: E. V. Gerasimova, et al.
Published: (2019-11-01)

Impact of obesity on echocardiographic parameters and N-terminal pro-brain natriuretic peptide levels in patients with heart failure with mid-range ejection fraction: unanswered questions
by: E. A. Lyasnikova, et al.
Published: (2021-07-01)

N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN DIAGNOSTICS OF NON-COMPACTED MYOCARDIUM IN CHILDREN
by: E. N. Arkhipova, et al.
Published: (2012-10-01)

The importance of NT proBNP in hypertensive patients management for preventing heart failure
by: Irina Cuciureanu, et al.
Published: (2021-03-01)

Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD [Corrigendum]
by: Li H, et al.
Published: (2020-02-01)

Analyse biochimique multi-paramétrique révélant une augmentation de l´homocystéinémie et de la NTProBNP chez les patients hypertendus à Bamako (Mali)
by: Yaya Goïta, et al.
Published: (2020-01-01)

Diagnostic value of NT–PRO BNP in cardiogenic and non cardiogenic pleural effusions
by: Mohamed E. Abdalla, et al.
Published: (2012-07-01)

Diagnostic Significance of the Level of Soluble Stimulating Growth Factor in Patients with Spondyloarthritis as an Early Marker of Cardiovascular Pathology
by: K. D. Dorogoykina, et al.
Published: (2022-05-01)

Characteristics of patients with chronic heart failure in different age groups
by: R. I. Jafarov, et al.
Published: (2023-05-01)

Biomarkers of heart failure: current state of problem
by: O. P. Ishevskaia, et al.
Published: (2021-12-01)

CLINICAL VALUE OF DETERMINING GALECTIN-3 IN PATIENTS WITH CHRONIC HEART FAILURE
by: K. A. Gyamdzhyan, et al.
Published: (2017-12-01)

Clinical and prognostic criteria for the course of heart failure in new coronavirus infection (COVID-19)
by: L.F. Burmistrova, et al.
Published: (2023-06-01)

sST2 Protein Serum Levels in Patients with Chronic Heart Failure
by: Roman E. Tokmachev, et al.
Published: (2020-12-01)

Estimation of immune response parameters in patients with frequent premature ventricular contractions without signs of organic pathology of the cardiovascular system
by: M M Rogova, et al.
Published: (2014-01-01)